Table 4 |
|||
|
Drug samples (in testable form for spectrometry analysis) failing quality testsa |
|||
|
Sampling |
Total Minilab failures |
Total visual inspection failures |
Total Raman spectrometry failures |
|
|
|||
|
Lagos 2007 |
(7/20) 35% |
(3/20) 15% |
(7/20) 35% |
|
|
|||
|
Lagos 2008 |
(18/112) 16.1% |
(11/112) 9.8% |
(28/112) 25% |
|
|
|||
|
Lagos 2010 |
(9/87) 10.3% |
(6/87) 6.9% |
(16/87) 18.4% |
|
|
|||
|
Lagos Total |
(34/219) 15.5% |
(20/219) 9.1% |
(51/219) 23.3% |
|
|
|||
|
Accra 2007 |
(12/34) 35.3% |
(4/34) 11.8% |
(14/34) 41.2% |
|
|
|||
|
Accra 2010 |
(9/47) 19.1% |
(5/47) 10.6% |
(14/47) 29.8% |
|
|
|||
|
Accra Total |
(21/81) 25.9% |
(9/81) 11.1% |
(28/81) 34.6% |
|
|
|||
|
TOTAL |
(55/300) 18.3% |
(29/300) 9.7% |
(79/300) 26.3% |
|
|
|||
|
a. Percentages are supported by (total that failed testing/total samples tested) |
|||
|
Bate and Hess Malaria Journal 2010 9:157 doi:10.1186/1475-2875-9-157 |
|||
